Citation

David M. Simpson, M.D., K. A. Citak, Ellen Godfrey, M.P.H., J. Godbold, D. E,. Wolfe. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?. Neurology. 1993 May 01; 43(5):971-6.

Citation

Susan A. Fiscus, Ph.D., James D. Folds, Ph.D., Charles van der Horst, M.D. Infectious immune complexes in HIV-1-infected patients. Viral Immunology. 1993 Jul 01; 6(2):135-41.

Citation

Linda L. Rosendorf, MS, Urania Dafni, Dsc, David A. Amato, PhD, Barbara Lunghofer, John G. Bartlett, M.D., John M. Leedom, MD, Diane W. Wara, MD, John A. Armstrong, Sc.D., Catherine Godfrey, M.D., Eivind Sukkestad, Georg W. Counts, MD. Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group. Controlled Clinical Trials. 1993 Dec 01; 14(6):523-7.

Citation

Ross E. McKinney, Jr., M.D., J. W. Robertson. Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit. Journal of Pediatrics. 1993 Oct 01; 123(4):579-82.

Citation

F. Boucher. Phase I Evaluation of Zidovudine Adminstered to Infants Exposed at Birth to the Human Immunodeficiency Virus. Journal of Pediatrics. 1993 Jan 01; 122(1):137-144.

Citation

Mary Jo O'Sullivan, M.D. The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082). American Journal of Obstetrics and Gynecology. 1993 May 01; 168(5):1510-1516.

Citation

E. Walter. Enhanced p24 Antigen Detection in Sera from HIV-Infected Children. Pediatric Infectious Disease Journal. 1993 Jan 01; 12(1):94-96.

Citation

D. Richardson, Song-Heng Liou, M.S., James O. Kahn, M.D. Uric acid and didanosine compliance in AIDS clinical trials: an analysis of AIDS Clinical Trials Group protocols 116A and 116B/117. Journal of Acquired Immune Deficiency Syndromes. 1993 Nov 01; 6(11):1212-23.

Citation

A. Berger, Joseph Arezzo, Herbert H. Schaumburg, Gail Skowron, M.D., Thomas C. Merigan, Jr., M.D., Sam Bozzette, M.D., Ph.D., Douglas D. Richman, M.D., Whaijen Soo, M.D., Ph.D. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology. 1993 Feb 01; 43(2):358-62.

Citation

Pamela Stratton, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Anne Willoughby, M.D., M.P.H. Human immunodeficiency virus infection in pregnant women under care at AIDS clinical trials centers in the United States. Obstetrics and Gynecology. 1993 Mar 01; 79(3):364-8.